Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Minority-serving hospitals had similar survival after liver cancer surgery

Key clinical point: Treatment at a minority-serving hospital was not associated with higher risk of death among patients undergoing surgery for hepatocellular carcinoma.

Major finding: The multivariable hazard ratio for death was 0.89 (95% confidence interval, 0.72-1.11).

Study details: Analysis of National Cancer Database for 2004-2014. All patients who underwent surgical resection for hepatocellular carcinoma were included.

Disclosures: Dr. Mehtsun reported having no relevant conflicts of interest.


Mehtsun WT et al. DDW 2020, Abstract Tu2043.